嶄新抗衰老療程

一步結合雙效優勢

許多抗衰老肌膚療程只能每次針對單一問題，例如面部豐盈度或膠原蛋白流失。1-6
HArmonyCa™美神針™療程能帶來持久又明顯的提升效果，並持續地由內而外刺激自身膠原蛋白再生。*, †,‡,7

*Results from a prospective and non-randomised interventional study where HArmonyCa™ was injected in the preauricular region of 15 women. The primary endpoint were the volumetric changes at Day 180. Secondary endpoints included changes in facial tension vectors, time to filler tissue integration and safety profile.7
†Ultrasound and elastography examinations were performed using the Samsung HT 30 ultrasound machine and the ElastoScan HS30/XH30 respectively (Samsung Healthcare Global). When compared to baseline, an increase in density, viscoelasticity, and firmness of the tissue was observed at 60 days and then confirmed at 90 days after treatment. At 180 days after treatment an increase in collagen in the treated areas was confirmed.7
‡ Vectra® H2 (Canfield Scientific, Inc.) was used to assess skin lift and tightening by measuring the changes in facial tension vectors (FTV) at 60, 90, and 180 days after treatment. As compared to pre-treatment values, FTV significantly increased at all timepoints with a median (interquartile-range) increased by 2.2 (1.6– 2.2) mm and 2.0 (1.7–2.2) mm in the right and left side, respectively p < 0.0001 each, 180 days after treatment.7

全新雙效療程8

刺激肌膚內的膠原蛋白再生*†,7

面部老化的常見問題包括肌膚失去豐盈感和軟組織結構失去支撐。1-3 作為雙效混合注射療程，HArmonyCa™美神針™高端結合透明質酸和CaHA8，透過注射至肌膚底層8，能全面地針對面部衰老的成因。HArmonyCa™美神針™的主要成份 CaHA能提升肌膚的緊緻度，並改善整體外觀。5 HArmonyCa™美神針™是專為因初老開始而令肌膚失去彈性及豐盈感而設。‡7,8

*Results from a prospective and non-randomised interventional study where HArmonyCa™ was injected in the preauricular region of 15 women. The primary endpoint were the volumetric changes at Day 180. Secondary endpoints included changes in facial tension vectors, time to filler tissue integration and safety profile.7
†Ultrasound and elastography examinations were performed using the Samsung HT 30 ultrasound machine and the ElastoScan HS30/XH30 respectively (Samsung Healthcare Global). When compared to baseline, an increase in density, viscoelasticity, and firmness of the tissue was observed at 60 days and then confirmed at 90 days after treatment. At 180 days after treatment an increase in collagen in the treated areas was confirmed.7
‡ HArmonyCa™ can be injected in the preauricular area and in the ascending and descending branches of the jaw.7,8

Eva, 39

HArmonyCa™美神針™與其他療程的不同之處

膠原蛋白讓您的肌膚重現豐盈感2

隨年齡增長，透明質酸、膠原蛋白和彈性蛋白會逐漸流失，讓肌膚逐漸變薄並失去彈性。2 不同的方法都能增加膠原蛋白，但膠原蛋白面霜和營養補充品都需要每天使用，才能為肌膚帶來人工添加膠原蛋白9，而HArmonyCa™美神針™則能在肌膚層直接刺激膠原蛋白再生8，由療程後第一個星期開始已經見效。*10

HArmonyCa™美神針™刺激肌膚自主新生膠原纖維，帶來更細密、更彈性、更緊緻的效果。† ,‡,7

*Results from a pre-clinical animal study of HArmonyCa™ with lidocaine, with results demonstrated over 8 weeks.10
† Ultrasound and elastography examinations were performed using the Samsung HT 30 ultrasound machine and the ElastoScan HS30/XH30 respectively (Samsung Healthcare Global) . When compared to baseline, an increase in density, viscoelasticity, and firmness of the tissue was observed at 60 days and then confirmed at 90 days after treatment. At 180 days after treatment an increase in collagen in the treated areas was confirmed.7
‡ Results from a prospective and non-randomised interventional study where HArmonyCa™ was injected in the preauricular region of 15 women. The primary endpoint were the volumetric changes at Day 180. Secondary endpoints included changes in facial tension vectors, time to filler tissue integration and safety profile.7

Lily, 39

常見問題

HArmonyCa™美神針™擁有良好的風險效益比*11

HArmonyCa™美神針™的長期安全跟進研究顯示，沒有發生與療程相關的持續不良事件。*†11 常見的副作用包括紅腫、疼痛、觸痛和痕癢，普遍會在24至48小時內得到改善，而腫脹則會在大約一周內完全消退。8

*In a post-marketing clinical analysis of HArmonyCa™ (N=162), conducted in Israel, one unrelated serious side effect was reported and one side effect required medical intervention due to material migration into the lips and over correction.5
†Time from treatment to last follow-up ranged from 1–4 to >24 months, with the majority between 12–24 months (65.4%). The long-term safety group included all 162 subjects. This follow-up considered long term side effects which still existed at the time of follow-up, serious side effects, and side effects which required special intervention.5

締造您專屬的療程方案12

接受任何療程前，醫生將全面評估您的療程記錄、療程目標和希望獲得改善的位置，以定制專屬的療程方案，確保獲得理想效果。8,13

HArmonyCa™美神針™含有輕度的局部麻醉劑利多卡因，可以讓您的療程更舒適。如有需要，醫生亦會為您評估疼痛管理的需求，並選擇合適的麻醉方式。此外，也可能在注射部位敷冰來減輕腫脹感。8

療程後或會出現一些副作用，包括紅、腫和刺激感。8 透過HArmonyCa™美神針™療程，不但能即現顯著提升，新生膠原亦會由第一個星期開始出現。*†,10,14

雖然不少人可以在一次臉部注射療程中就得到預期效果，但HArmonyCa™美神針™與其他療程並不一樣，再次接受後續治療可以更大限度地提高理想效果。

*Results from a pre-clinical animal study of HArmonyCa™ with lidocaine, with results demonstrated over 12 weeks.8
†Results from a pre-clinical animal study of HArmonyCa™ with lidocaine, with results demonstrated over 12 weeks.9

  1. Kahn DM and Shaw RB. Facial Plast Surg. 2010;26(5):350–55.
  2. Swift A et al. Aesthet Surg J. 2021;41(10):1107–19.
  3. Coleman SR and Grover R. Aesthet Surg J. 2006;26(1S):S4–9.
  4. Sanchez-Carpintero I et al. Actas Dermosifiliogr. 2010;101(5):381–93.
  5. Gonzaga da Cunha M et al. Surg Cosmet Dermatol. 2020;12(2):109–17.
  6. Hee C et al. Dermatol Surg. 2015;41(Suppl 1):S373–81.
  7. Urdiales-Gálvez F, et al. J Cosmet Dermatol. 2023. doi: 10.1111/jocd.15706.
  8. HArmonyCa™ IFU. 73960EU10. M049 V01. Revision December 2021.
  9. Aguirre-Cruz G et al. Antioxidants (Basel). 2020; 9(2):181.
  10. Allergan Aesthetics. Data on File. HArmonyCa™ Lidocaine INT-HAR-2150040. Collagen stimulation. July 2021.
  11. Allergan Aesthetics. Data on File. HArmonyCa™ Lidocaine. Clinical Study Report. July 2022.
  12. Bravo B et al. Plast Reconstr Surg Glob Open. 2023;15(11):1–10.
  13. Lipko-Godlewska S, et al. J Cosmet Dermatol. 2021;14:169–178.
  14. Allergan Aesthetics. Data on File. HArmonyCa™ Lidocaine INT-HAR2150036. Lift capacity. July 2021.